PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A. Financials Profarma Distribuidora de Produtos Farmacêuticos S.A.
Equities
PFRM3
BRPFRMACNOR1
Drug Retailers
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.76 BRL | -3.84% |
|
-5.57% | -5.57% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 481.9 | 793.3 | 747.9 | 723.4 | 450 | 747.9 |
| Enterprise Value (EV) 1 | 888.7 | 1,465 | 1,277 | 1,482 | 1,291 | 1,698 |
| P/E ratio | -47.3 x | 66.2 x | 14.3 x | 9.25 x | 5.56 x | 10.6 x |
| Yield | - | - | - | 4.59% | 4.72% | 1.9% |
| Capitalization / Revenue | 0.11 x | 0.17 x | 0.14 x | 0.11 x | 0.06 x | 0.09 x |
| EV / Revenue | 0.21 x | 0.31 x | 0.23 x | 0.23 x | 0.17 x | 0.2 x |
| EV / EBITDA | 10.5 x | 11.6 x | 8.52 x | 9.11 x | 4.54 x | 5.74 x |
| EV / FCF | -111 x | -55 x | -50.4 x | -136 x | -22.6 x | -101 x |
| FCF Yield | -0.9% | -1.82% | -1.98% | -0.73% | -4.42% | -0.99% |
| Price to Book | 0.47 x | 0.79 x | 0.71 x | 0.67 x | 0.38 x | 0.6 x |
| Nbr of stocks (in thousands) | 122,611 | 122,611 | 122,611 | 122,611 | 122,611 | 122,611 |
| Reference price 2 | 3.930 | 6.470 | 6.100 | 5.900 | 3.670 | 6.100 |
| Announcement Date | 3/21/19 | 3/11/20 | 3/16/21 | 3/16/22 | 3/15/23 | 3/7/24 |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4,271 | 4,801 | 5,481 | 6,413 | 7,816 | 8,662 |
| EBITDA 1 | 84.9 | 126.5 | 149.9 | 162.7 | 284.2 | 295.6 |
| EBIT 1 | 64.43 | 105.5 | 128.3 | 136.3 | 253.8 | 261.1 |
| Operating Margin | 1.51% | 2.2% | 2.34% | 2.12% | 3.25% | 3.01% |
| Earnings before Tax (EBT) 1 | -30.13 | 21.56 | 33.15 | 48.75 | 78.97 | 81.59 |
| Net income 1 | -9.734 | 11.98 | 52.33 | 78.19 | 80.87 | 70.4 |
| Net margin | -0.23% | 0.25% | 0.95% | 1.22% | 1.03% | 0.81% |
| EPS 2 | -0.0831 | 0.0977 | 0.4268 | 0.6377 | 0.6596 | 0.5740 |
| Free Cash Flow 1 | -8.034 | -26.62 | -25.32 | -10.87 | -57.05 | -16.86 |
| FCF margin | -0.19% | -0.55% | -0.46% | -0.17% | -0.73% | -0.19% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | 0.2706 | 0.1733 | 0.1157 |
| Announcement Date | 3/21/19 | 3/11/20 | 3/16/21 | 3/16/22 | 3/15/23 | 3/7/24 |
1BRL in Million2BRL
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 407 | 672 | 529 | 758 | 841 | 950 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 4.792 x | 5.307 x | 3.528 x | 4.661 x | 2.959 x | 3.213 x |
| Free Cash Flow 1 | -8.03 | -26.6 | -25.3 | -10.9 | -57 | -16.9 |
| ROE (net income / shareholders' equity) | -1.1% | 1.18% | 5.07% | 5.44% | 5.69% | 5.11% |
| ROA (Net income/ Total Assets) | 1.46% | 2.17% | 2.31% | 2.19% | 3.78% | 3.51% |
| Assets 1 | -665.9 | 551.9 | 2,267 | 3,578 | 2,141 | 2,006 |
| Book Value Per Share 2 | 8.330 | 8.190 | 8.530 | 8.860 | 9.710 | 10.20 |
| Cash Flow per Share 2 | 1.870 | 1.840 | 3.030 | 1.540 | 1.490 | 1.580 |
| Capex 1 | 12.1 | 21.4 | 36 | 68.5 | 60 | 67.5 |
| Capex / Sales | 0.28% | 0.45% | 0.66% | 1.07% | 0.77% | 0.78% |
| Announcement Date | 3/21/19 | 3/11/20 | 3/16/21 | 3/16/22 | 3/15/23 | 3/7/24 |
1BRL in Million2BRL
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -5.57% | 136M | |
| -33.59% | 15.3B | |
| -24.68% | 11.07B | |
| +9.74% | 6.13B | |
| -10.95% | 5.95B | |
| +0.88% | 4.79B | |
| +53.60% | 4.36B | |
| -10.49% | 3.69B | |
| -12.53% | 3.43B | |
| -6.87% | 3.05B |
- Stock Market
- Equities
- PFRM3 Stock
- Financials Profarma Distribuidora de Produtos Farmacêuticos S.A.
